

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 8.03700789 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 8.00835097 |
| 3 | omega-hydroxylase P450 pathway (GO:0097267) | 7.73865700 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.65919196 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.65919196 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 7.29809138 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.29809138 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.96963944 |
| 9 | tryptophan catabolic process (GO:0006569) | 6.34996728 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 6.34996728 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 6.34996728 |
| 12 | oxidative demethylation (GO:0070989) | 6.25202697 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.23796700 |
| 14 | kynurenine metabolic process (GO:0070189) | 6.16713976 |
| 15 | bile acid biosynthetic process (GO:0006699) | 6.10662092 |
| 16 | drug metabolic process (GO:0017144) | 6.02313035 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.97661098 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.80237473 |
| 19 | urea metabolic process (GO:0019627) | 5.79250585 |
| 20 | urea cycle (GO:0000050) | 5.79250585 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.60068792 |
| 22 | complement activation, alternative pathway (GO:0006957) | 5.55444673 |
| 23 | phenylpropanoid metabolic process (GO:0009698) | 5.52794251 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 5.50776518 |
| 25 | regulation of protein activation cascade (GO:2000257) | 5.47811509 |
| 26 | alpha-linolenic acid metabolic process (GO:0036109) | 5.45824831 |
| 27 | regulation of fibrinolysis (GO:0051917) | 5.43999969 |
| 28 | protein carboxylation (GO:0018214) | 5.41384789 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.41384789 |
| 30 | cysteine metabolic process (GO:0006534) | 5.39597700 |
| 31 | sulfur amino acid catabolic process (GO:0000098) | 5.37561020 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 5.32733630 |
| 33 | bile acid metabolic process (GO:0008206) | 5.20037975 |
| 34 | serine family amino acid catabolic process (GO:0009071) | 5.18595611 |
| 35 | regulation of complement activation (GO:0030449) | 5.13794611 |
| 36 | aromatic amino acid family metabolic process (GO:0009072) | 5.06265361 |
| 37 | negative regulation of protein activation cascade (GO:2000258) | 4.97585866 |
| 38 | homocysteine metabolic process (GO:0050667) | 4.91814834 |
| 39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.89477390 |
| 40 | ethanol metabolic process (GO:0006067) | 4.89250464 |
| 41 | tyrosine metabolic process (GO:0006570) | 4.89097392 |
| 42 | regulation of humoral immune response (GO:0002920) | 4.88818387 |
| 43 | alkaloid metabolic process (GO:0009820) | 4.82206905 |
| 44 | regulation of plasminogen activation (GO:0010755) | 4.81196717 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 4.81099406 |
| 46 | regulation of cholesterol esterification (GO:0010872) | 4.78976459 |
| 47 | reverse cholesterol transport (GO:0043691) | 4.77584014 |
| 48 | acute-phase response (GO:0006953) | 4.76445483 |
| 49 | alpha-amino acid catabolic process (GO:1901606) | 4.72420850 |
| 50 | S-adenosylmethionine metabolic process (GO:0046500) | 4.72403767 |
| 51 | plasma lipoprotein particle remodeling (GO:0034369) | 4.71483166 |
| 52 | protein-lipid complex remodeling (GO:0034368) | 4.71483166 |
| 53 | macromolecular complex remodeling (GO:0034367) | 4.71483166 |
| 54 | negative regulation of hemostasis (GO:1900047) | 4.68158080 |
| 55 | negative regulation of blood coagulation (GO:0030195) | 4.68158080 |
| 56 | amino-acid betaine metabolic process (GO:0006577) | 4.64216280 |
| 57 | lysine catabolic process (GO:0006554) | 4.62446205 |
| 58 | lysine metabolic process (GO:0006553) | 4.62446205 |
| 59 | hormone catabolic process (GO:0042447) | 4.61082658 |
| 60 | acylglycerol homeostasis (GO:0055090) | 4.59359981 |
| 61 | triglyceride homeostasis (GO:0070328) | 4.59359981 |
| 62 | indolalkylamine metabolic process (GO:0006586) | 4.51427470 |
| 63 | negative regulation of cholesterol transport (GO:0032375) | 4.50573089 |
| 64 | negative regulation of sterol transport (GO:0032372) | 4.50573089 |
| 65 | glycine metabolic process (GO:0006544) | 4.48910617 |
| 66 | bile acid and bile salt transport (GO:0015721) | 4.48782579 |
| 67 | imidazole-containing compound metabolic process (GO:0052803) | 4.48260784 |
| 68 | phospholipid efflux (GO:0033700) | 4.48076204 |
| 69 | coenzyme catabolic process (GO:0009109) | 4.45995817 |
| 70 | amine catabolic process (GO:0009310) | 4.42656664 |
| 71 | cellular biogenic amine catabolic process (GO:0042402) | 4.42656664 |
| 72 | cellular glucuronidation (GO:0052695) | 4.42462895 |
| 73 | cellular ketone body metabolic process (GO:0046950) | 4.40323545 |
| 74 | negative regulation of wound healing (GO:0061045) | 4.34218284 |
| 75 | cellular amino acid catabolic process (GO:0009063) | 4.33332765 |
| 76 | plasma lipoprotein particle clearance (GO:0034381) | 4.29621372 |
| 77 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.29443902 |
| 78 | glutamate metabolic process (GO:0006536) | 4.25095588 |
| 79 | negative regulation of coagulation (GO:0050819) | 4.24733433 |
| 80 | serine family amino acid metabolic process (GO:0009069) | 4.23666381 |
| 81 | cholesterol efflux (GO:0033344) | 4.17857470 |
| 82 | benzene-containing compound metabolic process (GO:0042537) | 4.17499317 |
| 83 | ethanol oxidation (GO:0006069) | 4.12673097 |
| 84 | aldehyde catabolic process (GO:0046185) | 4.10892490 |
| 85 | arginine metabolic process (GO:0006525) | 4.08621505 |
| 86 | negative regulation of complement activation (GO:0045916) | 4.07884493 |
| 87 | serine family amino acid biosynthetic process (GO:0009070) | 4.05449144 |
| 88 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.04792530 |
| 89 | cellular modified amino acid catabolic process (GO:0042219) | 4.04662204 |
| 90 | low-density lipoprotein particle remodeling (GO:0034374) | 4.03829703 |
| 91 | fibrinolysis (GO:0042730) | 4.03268125 |
| 92 | flavonoid metabolic process (GO:0009812) | 3.97480446 |
| 93 | uronic acid metabolic process (GO:0006063) | 3.93089927 |
| 94 | glucuronate metabolic process (GO:0019585) | 3.93089927 |
| 95 | drug catabolic process (GO:0042737) | 3.92570823 |
| 96 | plasma lipoprotein particle assembly (GO:0034377) | 3.92511331 |
| 97 | positive regulation of blood coagulation (GO:0030194) | 3.92134015 |
| 98 | positive regulation of hemostasis (GO:1900048) | 3.92134015 |
| 99 | blood coagulation, intrinsic pathway (GO:0007597) | 3.90279773 |
| 100 | complement activation, classical pathway (GO:0006958) | 3.89025009 |
| 101 | steroid catabolic process (GO:0006706) | 3.87399620 |
| 102 | regulation of lipoprotein particle clearance (GO:0010984) | 3.86787781 |
| 103 | heme transport (GO:0015886) | 3.86576306 |
| 104 | cofactor catabolic process (GO:0051187) | 3.85391255 |
| 105 | cytolysis (GO:0019835) | 3.84317479 |
| 106 | regulation of bile acid biosynthetic process (GO:0070857) | 3.82389583 |
| 107 | ketone body metabolic process (GO:1902224) | 3.81028846 |
| 108 | carboxylic acid catabolic process (GO:0046395) | 3.77614505 |
| 109 | organic acid catabolic process (GO:0016054) | 3.77614505 |
| 110 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.75353066 |
| 111 | acute inflammatory response (GO:0002526) | 3.73472599 |
| 112 | cholesterol homeostasis (GO:0042632) | 3.72133360 |
| 113 | negative regulation of lipase activity (GO:0060192) | 3.72087538 |
| 114 | * protein activation cascade (GO:0072376) | 3.71186659 |
| 115 | phospholipid homeostasis (GO:0055091) | 3.70936146 |
| 116 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.70548589 |
| 117 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.70548589 |
| 118 | positive regulation of lipid catabolic process (GO:0050996) | 3.69956413 |
| 119 | * complement activation (GO:0006956) | 3.69465655 |
| 120 | acetyl-CoA metabolic process (GO:0006084) | 3.69166064 |
| 121 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.68249217 |
| 122 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.68249217 |
| 123 | NAD biosynthetic process (GO:0009435) | 3.66295786 |
| 124 | sterol homeostasis (GO:0055092) | 3.65860718 |
| 125 | short-chain fatty acid metabolic process (GO:0046459) | 3.65566422 |
| 126 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.58936620 |
| 127 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.58936620 |
| 128 | arginine catabolic process (GO:0006527) | 3.58446910 |
| 129 | positive regulation of coagulation (GO:0050820) | 3.57811103 |
| 130 | plasma lipoprotein particle organization (GO:0071827) | 3.57712343 |
| 131 | xenobiotic metabolic process (GO:0006805) | 3.55389849 |
| 132 | regulation of acute inflammatory response (GO:0002673) | 3.54600260 |
| 133 | opsonization (GO:0008228) | 3.52862810 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.40408287 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.26130002 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.16241390 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.50695444 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.31330305 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.19431200 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.66386735 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.09482519 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.05873007 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08949533 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9936096 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.94876872 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.89299203 |
| 14 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.65650265 |
| 15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57418304 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 1.44038786 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.41705675 |
| 18 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39584992 |
| 19 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.26321921 |
| 20 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.21184857 |
| 21 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.21101565 |
| 22 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.19967920 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19850255 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.18195758 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.15373235 |
| 26 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.14867053 |
| 27 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.14375565 |
| 28 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.13041311 |
| 29 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.12270336 |
| 30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10931877 |
| 31 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.10334431 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.09569911 |
| 33 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.07689468 |
| 34 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.07342084 |
| 35 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.06014007 |
| 36 | * PHF8_20622853_ChIP-Seq_HELA_Human | 1.05452559 |
| 37 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00967408 |
| 38 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.00383910 |
| 39 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.99211939 |
| 40 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98861348 |
| 41 | NFYA_21822215_ChIP-Seq_K562_Human | 0.98233478 |
| 42 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.96627583 |
| 43 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.93808700 |
| 44 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.92915577 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.92713917 |
| 46 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.92228855 |
| 47 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.87133249 |
| 48 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.87053028 |
| 49 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.86967992 |
| 50 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.86428612 |
| 51 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.85323466 |
| 52 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.85276258 |
| 53 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85003588 |
| 54 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.82879392 |
| 55 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.82141357 |
| 56 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.79999584 |
| 57 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.77747821 |
| 58 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.77471147 |
| 59 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.77471147 |
| 60 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.77221657 |
| 61 | NFYB_21822215_ChIP-Seq_K562_Human | 0.77078307 |
| 62 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.76819979 |
| 63 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.76803486 |
| 64 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.75964707 |
| 65 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.75934510 |
| 66 | ERA_21632823_ChIP-Seq_H3396_Human | 0.75821983 |
| 67 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75586085 |
| 68 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.75425445 |
| 69 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.75058414 |
| 70 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.74505019 |
| 71 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.74456625 |
| 72 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74427892 |
| 73 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72850870 |
| 74 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.72418157 |
| 75 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.72418157 |
| 76 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.72371098 |
| 77 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.71817341 |
| 78 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.71615061 |
| 79 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.71307165 |
| 80 | * NCOR_22424771_ChIP-Seq_293T_Human | 0.71089072 |
| 81 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.70704473 |
| 82 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69508413 |
| 83 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.69443924 |
| 84 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.68404376 |
| 85 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.68013129 |
| 86 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.68013129 |
| 87 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.67834554 |
| 88 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.67355134 |
| 89 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.66423379 |
| 90 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.66160511 |
| 91 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65780967 |
| 92 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65200185 |
| 93 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.64746713 |
| 94 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.63677907 |
| 95 | * ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.63660597 |
| 96 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.62470765 |
| 97 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.61993270 |
| 98 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61901506 |
| 99 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61243679 |
| 100 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.60410422 |
| 101 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57441606 |
| 102 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.57341928 |
| 103 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.57337865 |
| 104 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.57023875 |
| 105 | AR_20517297_ChIP-Seq_VCAP_Human | 0.55904916 |
| 106 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.54856937 |
| 107 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.54062740 |
| 108 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.53991884 |
| 109 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52745810 |
| 110 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52304968 |
| 111 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51710706 |
| 112 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51383414 |
| 113 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.51101501 |
| 114 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50430091 |
| 115 | CBP_21632823_ChIP-Seq_H3396_Human | 0.50275759 |
| 116 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48051473 |
| 117 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47001821 |
| 118 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46173161 |
| 119 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.46119379 |
| 120 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.45945378 |
| 121 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.45793616 |
| 122 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44207919 |
| 123 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.42970159 |
| 124 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.42676850 |
| 125 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.41862621 |
| 126 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40953470 |
| 127 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.40642137 |
| 128 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.40342692 |
| 129 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.40084766 |
| 130 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.39954780 |
| 131 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.39747198 |
| 132 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.39477245 |
| 133 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.38143883 |
| 134 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.37899436 |
| 135 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.37603548 |
| 136 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.36712941 |
| 137 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36217756 |
| 138 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.36070701 |
| 139 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.36023611 |
| 140 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.35779409 |
| 141 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35777078 |
| 142 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.35267825 |
| 143 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.35046094 |
| 144 | GATA2_19941826_ChIP-Seq_K562_Human | 0.34497347 |
| 145 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.34411265 |
| 146 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.34361876 |
| 147 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.34051555 |
| 148 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.34040413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.32431968 |
| 2 | MP0005360_urolithiasis | 7.64308472 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.55346709 |
| 4 | MP0005365_abnormal_bile_salt | 6.19784933 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.23024258 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.35852203 |
| 7 | MP0003252_abnormal_bile_duct | 3.94913187 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.55431583 |
| 9 | MP0009840_abnormal_foam_cell | 3.15585237 |
| 10 | MP0005083_abnormal_biliary_tract | 2.98556711 |
| 11 | MP0003195_calcinosis | 2.85667368 |
| 12 | MP0005332_abnormal_amino_acid | 2.75699087 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.58621017 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.20944468 |
| 15 | MP0000609_abnormal_liver_physiology | 2.14385483 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.13864394 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.08029595 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.99837658 |
| 19 | MP0003868_abnormal_feces_composition | 1.98381303 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.83093835 |
| 21 | MP0001764_abnormal_homeostasis | 1.72439604 |
| 22 | MP0009697_abnormal_copulation | 1.67391083 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56025744 |
| 24 | MP0005451_abnormal_body_composition | 1.38925883 |
| 25 | MP0003011_delayed_dark_adaptation | 1.35686294 |
| 26 | MP0003186_abnormal_redox_activity | 1.30486335 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.25004521 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.20666415 |
| 29 | MP0000598_abnormal_liver_morphology | 1.17198419 |
| 30 | MP0005647_abnormal_sex_gland | 1.15907892 |
| 31 | MP0009764_decreased_sensitivity_to | 1.10917816 |
| 32 | MP0005187_abnormal_penis_morphology | 1.06346742 |
| 33 | MP0009763_increased_sensitivity_to | 1.03246629 |
| 34 | MP0003705_abnormal_hypodermis_morpholog | 1.02175777 |
| 35 | MP0000604_amyloidosis | 1.00669597 |
| 36 | MP0002254_reproductive_system_inflammat | 0.99028482 |
| 37 | MP0010368_abnormal_lymphatic_system | 0.93190393 |
| 38 | MP0008469_abnormal_protein_level | 0.90883082 |
| 39 | MP0005636_abnormal_mineral_homeostasis | 0.89521787 |
| 40 | MP0005408_hypopigmentation | 0.86803597 |
| 41 | MP0009642_abnormal_blood_homeostasis | 0.86586906 |
| 42 | MP0005670_abnormal_white_adipose | 0.83876322 |
| 43 | MP0006036_abnormal_mitochondrial_physio | 0.82538117 |
| 44 | MP0009765_abnormal_xenobiotic_induced | 0.81041790 |
| 45 | MP0002876_abnormal_thyroid_physiology | 0.80780001 |
| 46 | MP0005376_homeostasis/metabolism_phenot | 0.80407852 |
| 47 | MP0002282_abnormal_trachea_morphology | 0.76520875 |
| 48 | MP0005084_abnormal_gallbladder_morpholo | 0.76282069 |
| 49 | MP0002078_abnormal_glucose_homeostasis | 0.75750974 |
| 50 | MP0005220_abnormal_exocrine_pancreas | 0.72422905 |
| 51 | MP0002971_abnormal_brown_adipose | 0.69155747 |
| 52 | MP0005535_abnormal_body_temperature | 0.68494189 |
| 53 | MP0003879_abnormal_hair_cell | 0.67862876 |
| 54 | MP0004130_abnormal_muscle_cell | 0.67624860 |
| 55 | MP0005334_abnormal_fat_pad | 0.67593634 |
| 56 | MP0010386_abnormal_urinary_bladder | 0.67151868 |
| 57 | MP0001661_extended_life_span | 0.67131121 |
| 58 | MP0005266_abnormal_metabolism | 0.66046735 |
| 59 | MP0003690_abnormal_glial_cell | 0.65196069 |
| 60 | MP0001915_intracranial_hemorrhage | 0.64817899 |
| 61 | MP0009053_abnormal_anal_canal | 0.62600885 |
| 62 | MP0000566_synostosis | 0.60743327 |
| 63 | MP0000639_abnormal_adrenal_gland | 0.59233980 |
| 64 | MP0006035_abnormal_mitochondrial_morpho | 0.57329447 |
| 65 | MP0009785_altered_susceptibility_to | 0.55559048 |
| 66 | MP0002249_abnormal_larynx_morphology | 0.55204848 |
| 67 | MP0001756_abnormal_urination | 0.54331529 |
| 68 | MP0005448_abnormal_energy_balance | 0.53502080 |
| 69 | MP0003329_amyloid_beta_deposits | 0.53052523 |
| 70 | MP0005464_abnormal_platelet_physiology | 0.52125026 |
| 71 | MP0002822_catalepsy | 0.50623055 |
| 72 | MP0004782_abnormal_surfactant_physiolog | 0.49328032 |
| 73 | MP0004381_abnormal_hair_follicle | 0.48400554 |
| 74 | MP0003718_maternal_effect | 0.48032605 |
| 75 | MP0005395_other_phenotype | 0.47459651 |
| 76 | MP0003724_increased_susceptibility_to | 0.46510917 |
| 77 | MP0008874_decreased_physiological_sensi | 0.46451361 |
| 78 | MP0003436_decreased_susceptibility_to | 0.45533407 |
| 79 | MP0002928_abnormal_bile_duct | 0.45464511 |
| 80 | MP0003638_abnormal_response/metabolism_ | 0.45438764 |
| 81 | MP0008873_increased_physiological_sensi | 0.45275012 |
| 82 | MP0005248_abnormal_Harderian_gland | 0.44987655 |
| 83 | MP0002136_abnormal_kidney_physiology | 0.43080721 |
| 84 | MP0005645_abnormal_hypothalamus_physiol | 0.42208698 |
| 85 | MP0003959_abnormal_lean_body | 0.40625054 |
| 86 | MP0001986_abnormal_taste_sensitivity | 0.40402391 |
| 87 | MP0004142_abnormal_muscle_tone | 0.40008555 |
| 88 | MP0003953_abnormal_hormone_level | 0.39434487 |
| 89 | MP0005166_decreased_susceptibility_to | 0.39099078 |
| 90 | MP0008872_abnormal_physiological_respon | 0.38945916 |
| 91 | MP0003075_altered_response_to | 0.37984027 |
| 92 | MP0000579_abnormal_nail_morphology | 0.37247909 |
| 93 | MP0002837_dystrophic_cardiac_calcinosis | 0.37069440 |
| 94 | MP0005551_abnormal_eye_electrophysiolog | 0.36747522 |
| 95 | MP0006082_CNS_inflammation | 0.35862721 |
| 96 | MP0009672_abnormal_birth_weight | 0.35410518 |
| 97 | MP0005666_abnormal_adipose_tissue | 0.32046696 |
| 98 | MP0009115_abnormal_fat_cell | 0.30969615 |
| 99 | MP0000230_abnormal_systemic_arterial | 0.30915388 |
| 100 | MP0000249_abnormal_blood_vessel | 0.30247694 |
| 101 | MP0002132_abnormal_respiratory_system | 0.29907891 |
| 102 | MP0001243_abnormal_dermal_layer | 0.29890217 |
| 103 | MP0001853_heart_inflammation | 0.29794850 |
| 104 | MP0005167_abnormal_blood-brain_barrier | 0.29483385 |
| 105 | MP0002796_impaired_skin_barrier | 0.29243281 |
| 106 | MP0001845_abnormal_inflammatory_respons | 0.28867645 |
| 107 | MP0002168_other_aberrant_phenotype | 0.28036735 |
| 108 | MP0009384_cardiac_valve_regurgitation | 0.28019849 |
| 109 | MP0002970_abnormal_white_adipose | 0.27444909 |
| 110 | MP0001881_abnormal_mammary_gland | 0.26860555 |
| 111 | MP0004883_abnormal_blood_vessel | 0.26535735 |
| 112 | MP0002332_abnormal_exercise_endurance | 0.25711054 |
| 113 | MP0001324_abnormal_eye_pigmentation | 0.24138549 |
| 114 | MP0002060_abnormal_skin_morphology | 0.23892009 |
| 115 | MP0002090_abnormal_vision | 0.23024660 |
| 116 | MP0005023_abnormal_wound_healing | 0.22638184 |
| 117 | MP0001440_abnormal_grooming_behavior | 0.22331936 |
| 118 | MP0005164_abnormal_response_to | 0.21987814 |
| 119 | MP0003633_abnormal_nervous_system | 0.21922597 |
| 120 | MP0005197_abnormal_uvea_morphology | 0.21891904 |
| 121 | MP0004043_abnormal_pH_regulation | 0.21614788 |
| 122 | MP0000467_abnormal_esophagus_morphology | 0.20672160 |
| 123 | MP0001944_abnormal_pancreas_morphology | 0.20565335 |
| 124 | MP0003632_abnormal_nervous_system | 0.20309696 |
| 125 | MP0005646_abnormal_pituitary_gland | 0.19386212 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.46702861 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.46494506 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.45137872 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.76250306 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.73536417 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.46528329 |
| 7 | Xanthomatosis (HP:0000991) | 6.25705235 |
| 8 | Complement deficiency (HP:0004431) | 5.64420886 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.58145788 |
| 10 | Joint hemorrhage (HP:0005261) | 4.88657932 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.78156293 |
| 12 | Epidermoid cyst (HP:0200040) | 4.63742170 |
| 13 | Hyperammonemia (HP:0001987) | 4.61058416 |
| 14 | Hyperglycinemia (HP:0002154) | 4.48867437 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.48233269 |
| 16 | Abnormality of methionine metabolism (HP:0010901) | 4.39908113 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.39553004 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.30704554 |
| 19 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.21588583 |
| 20 | Fat malabsorption (HP:0002630) | 4.21238747 |
| 21 | Ketosis (HP:0001946) | 4.20230343 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.16941616 |
| 23 | Abnormality of complement system (HP:0005339) | 4.12089927 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 4.12083942 |
| 25 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.96969050 |
| 26 | Hyperglycinuria (HP:0003108) | 3.93532658 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.91417846 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.91417846 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.82222254 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.81963589 |
| 31 | Hypoglycemic coma (HP:0001325) | 3.77024775 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.63691633 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.39763465 |
| 34 | Hyperbilirubinemia (HP:0002904) | 3.37254267 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.32780993 |
| 36 | Steatorrhea (HP:0002570) | 3.21728929 |
| 37 | Abnormality of serum amino acid levels (HP:0003112) | 3.16773821 |
| 38 | Delayed CNS myelination (HP:0002188) | 3.15042961 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.07534331 |
| 40 | Hypochromic microcytic anemia (HP:0004840) | 3.03092355 |
| 41 | Spontaneous abortion (HP:0005268) | 3.02380928 |
| 42 | Hepatocellular carcinoma (HP:0001402) | 3.00657094 |
| 43 | Myocardial infarction (HP:0001658) | 2.95030597 |
| 44 | Ketoacidosis (HP:0001993) | 2.94066545 |
| 45 | Systemic lupus erythematosus (HP:0002725) | 2.83694588 |
| 46 | Skin nodule (HP:0200036) | 2.81650106 |
| 47 | Osteomalacia (HP:0002749) | 2.81514099 |
| 48 | Reduced antithrombin III activity (HP:0001976) | 2.80961468 |
| 49 | Metabolic acidosis (HP:0001942) | 2.75190252 |
| 50 | Fair hair (HP:0002286) | 2.67854262 |
| 51 | Lethargy (HP:0001254) | 2.63842577 |
| 52 | Abnormality of purine metabolism (HP:0004352) | 2.62816971 |
| 53 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.60245008 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.56488085 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.56488085 |
| 56 | Vascular calcification (HP:0004934) | 2.54368940 |
| 57 | Acanthocytosis (HP:0001927) | 2.54051786 |
| 58 | Glomerulonephritis (HP:0000099) | 2.52519554 |
| 59 | Pulmonary embolism (HP:0002204) | 2.49909751 |
| 60 | Purpura (HP:0000979) | 2.48641332 |
| 61 | Cerebral edema (HP:0002181) | 2.48254877 |
| 62 | Spastic diplegia (HP:0001264) | 2.45258690 |
| 63 | Abnormal gallbladder morphology (HP:0012437) | 2.44646715 |
| 64 | Hypoglycemic seizures (HP:0002173) | 2.42149234 |
| 65 | Mitral stenosis (HP:0001718) | 2.40898567 |
| 66 | Cholelithiasis (HP:0001081) | 2.36715251 |
| 67 | Gout (HP:0001997) | 2.36053547 |
| 68 | Neonatal onset (HP:0003623) | 2.35656895 |
| 69 | Irritability (HP:0000737) | 2.34634834 |
| 70 | Cholecystitis (HP:0001082) | 2.27370322 |
| 71 | Abnormal gallbladder physiology (HP:0012438) | 2.27370322 |
| 72 | Cardiovascular calcification (HP:0011915) | 2.24354891 |
| 73 | Gingival bleeding (HP:0000225) | 2.21700081 |
| 74 | Amyloidosis (HP:0011034) | 2.20916708 |
| 75 | Arthropathy (HP:0003040) | 2.19932534 |
| 76 | Hyperphosphaturia (HP:0003109) | 2.19606375 |
| 77 | Malnutrition (HP:0004395) | 2.18119542 |
| 78 | Enlarged kidneys (HP:0000105) | 2.15670745 |
| 79 | Pancreatitis (HP:0001733) | 2.14665431 |
| 80 | Menorrhagia (HP:0000132) | 2.14259794 |
| 81 | Brushfield spots (HP:0001088) | 2.13461432 |
| 82 | Esophageal varix (HP:0002040) | 2.13367085 |
| 83 | Bile duct proliferation (HP:0001408) | 2.12797282 |
| 84 | Abnormal biliary tract physiology (HP:0012439) | 2.12797282 |
| 85 | Sensorimotor neuropathy (HP:0007141) | 2.11918359 |
| 86 | Neonatal hypoglycemia (HP:0001998) | 2.10620943 |
| 87 | Glycosuria (HP:0003076) | 2.10372217 |
| 88 | Abnormality of urine glucose concentration (HP:0011016) | 2.10372217 |
| 89 | Thrombophlebitis (HP:0004418) | 2.08099074 |
| 90 | Vomiting (HP:0002013) | 2.05711849 |
| 91 | Opisthotonus (HP:0002179) | 2.03766774 |
| 92 | Generalized aminoaciduria (HP:0002909) | 2.01747236 |
| 93 | Late onset (HP:0003584) | 2.01242340 |
| 94 | Poikilocytosis (HP:0004447) | 1.99742457 |
| 95 | Abnormality of the gallbladder (HP:0005264) | 1.98612165 |
| 96 | Renal cortical cysts (HP:0000803) | 1.98200842 |
| 97 | Gangrene (HP:0100758) | 1.96716129 |
| 98 | Increased serum ferritin (HP:0003281) | 1.96140345 |
| 99 | Hemorrhage of the eye (HP:0011885) | 1.95811664 |
| 100 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.95132622 |
| 101 | Elevated alkaline phosphatase (HP:0003155) | 1.94326427 |
| 102 | Rickets (HP:0002748) | 1.90524436 |
| 103 | Generalized hypopigmentation of hair (HP:0011358) | 1.88365736 |
| 104 | Abnormality of iron homeostasis (HP:0011031) | 1.86512812 |
| 105 | Abnormal cartilage morphology (HP:0002763) | 1.84828744 |
| 106 | Hypophosphatemic rickets (HP:0004912) | 1.84734837 |
| 107 | Joint swelling (HP:0001386) | 1.84031716 |
| 108 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.83667933 |
| 109 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.83557470 |
| 110 | Elevated hepatic transaminases (HP:0002910) | 1.83493033 |
| 111 | Alkalosis (HP:0001948) | 1.82485590 |
| 112 | Abnormality of proline metabolism (HP:0010907) | 1.80391844 |
| 113 | Hydroxyprolinuria (HP:0003080) | 1.80391844 |
| 114 | Cerebral palsy (HP:0100021) | 1.79390588 |
| 115 | Status epilepticus (HP:0002133) | 1.79091427 |
| 116 | Abnormality of vitamin metabolism (HP:0100508) | 1.78926309 |
| 117 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.78138510 |
| 118 | Nephritis (HP:0000123) | 1.76385341 |
| 119 | Abnormal urine phosphate concentration (HP:0012599) | 1.73900634 |
| 120 | Hyperglycemia (HP:0003074) | 1.70744920 |
| 121 | Facial shape deformation (HP:0011334) | 1.69671458 |
| 122 | Potter facies (HP:0002009) | 1.69671458 |
| 123 | Abnormality of the Achilles tendon (HP:0005109) | 1.61336027 |
| 124 | Atrioventricular block (HP:0001678) | 1.61278741 |
| 125 | Epistaxis (HP:0000421) | 1.60501195 |
| 126 | Blue irides (HP:0000635) | 1.55989325 |
| 127 | Bifid scrotum (HP:0000048) | 1.49940095 |
| 128 | Decreased subcutaneous fat (HP:0001002) | 1.45353854 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.21271682 |
| 2 | FGFR4 | 4.76616325 |
| 3 | SIK1 | 4.54815804 |
| 4 | ERN1 | 4.07913857 |
| 5 | TAOK3 | 3.17279448 |
| 6 | INSRR | 3.10519211 |
| 7 | ERBB4 | 3.08594994 |
| 8 | MAP2K4 | 2.33418500 |
| 9 | WNK3 | 2.26960099 |
| 10 | ADRBK2 | 2.16009874 |
| 11 | MST1R | 2.13943514 |
| 12 | PKN2 | 2.01095751 |
| 13 | MAPK11 | 1.98587532 |
| 14 | FLT3 | 1.92786001 |
| 15 | TYK2 | 1.86436761 |
| 16 | PIK3CG | 1.82448368 |
| 17 | MAP4K2 | 1.72600428 |
| 18 | TLK1 | 1.71513904 |
| 19 | CASK | 1.66965903 |
| 20 | LATS1 | 1.64356572 |
| 21 | ABL2 | 1.56245511 |
| 22 | FRK | 1.55726040 |
| 23 | FGFR2 | 1.52343402 |
| 24 | CAMKK2 | 1.50207771 |
| 25 | NEK9 | 1.46408229 |
| 26 | NTRK3 | 1.45803427 |
| 27 | DAPK2 | 1.45193879 |
| 28 | TNK2 | 1.40324896 |
| 29 | PTK6 | 1.40219086 |
| 30 | PINK1 | 1.31891247 |
| 31 | TRIB3 | 1.27374182 |
| 32 | ACVR1B | 1.27200678 |
| 33 | MAP3K14 | 1.26444313 |
| 34 | MUSK | 1.25963828 |
| 35 | KDR | 1.23983485 |
| 36 | JAK2 | 1.23876650 |
| 37 | BMPR1B | 1.20490523 |
| 38 | PRKACA | 1.19625391 |
| 39 | BLK | 1.18552063 |
| 40 | MAP3K7 | 1.16899541 |
| 41 | PRKG1 | 1.16246823 |
| 42 | TXK | 1.12506544 |
| 43 | TBK1 | 1.10816211 |
| 44 | JAK1 | 1.09507880 |
| 45 | PRKAA2 | 1.09097662 |
| 46 | ERBB2 | 1.03498471 |
| 47 | MAP2K2 | 1.03309421 |
| 48 | GRK6 | 1.00166310 |
| 49 | MAPK4 | 0.99962577 |
| 50 | STK38L | 0.99906213 |
| 51 | CAMKK1 | 0.99088360 |
| 52 | WNK4 | 0.96491740 |
| 53 | MAP2K3 | 0.93764182 |
| 54 | PRKCZ | 0.93756628 |
| 55 | IRAK3 | 0.90385229 |
| 56 | TIE1 | 0.85414461 |
| 57 | CSNK1D | 0.84875854 |
| 58 | DYRK2 | 0.84287461 |
| 59 | MET | 0.83594347 |
| 60 | MAPK15 | 0.83316013 |
| 61 | ADRBK1 | 0.82176878 |
| 62 | MAP3K10 | 0.80775602 |
| 63 | PRKCE | 0.79758491 |
| 64 | MAPK12 | 0.79384096 |
| 65 | CDK6 | 0.79179989 |
| 66 | CAMK2G | 0.76812123 |
| 67 | EPHA3 | 0.76372387 |
| 68 | IKBKE | 0.76023503 |
| 69 | PRKACG | 0.75566976 |
| 70 | MAP3K3 | 0.74482604 |
| 71 | FGFR3 | 0.72554480 |
| 72 | MAP2K6 | 0.71521687 |
| 73 | PAK3 | 0.70999944 |
| 74 | CSK | 0.70494903 |
| 75 | PRKACB | 0.69142958 |
| 76 | PRKCB | 0.68877115 |
| 77 | EPHB1 | 0.68387127 |
| 78 | MAP3K11 | 0.66561301 |
| 79 | SGK3 | 0.66524888 |
| 80 | FER | 0.66436826 |
| 81 | NLK | 0.64475314 |
| 82 | PRKAA1 | 0.63518815 |
| 83 | DYRK1B | 0.62855850 |
| 84 | MAPK7 | 0.62640432 |
| 85 | GRK7 | 0.60970789 |
| 86 | GSK3A | 0.60014485 |
| 87 | CSF1R | 0.59375634 |
| 88 | RPS6KA3 | 0.59001481 |
| 89 | TGFBR2 | 0.58654844 |
| 90 | ZAK | 0.56850039 |
| 91 | TAOK2 | 0.56706681 |
| 92 | SGK1 | 0.56601124 |
| 93 | CSNK1G1 | 0.55541171 |
| 94 | PBK | 0.55426154 |
| 95 | PRKCQ | 0.55229441 |
| 96 | SGK2 | 0.55163144 |
| 97 | GRK1 | 0.54895657 |
| 98 | CAMK1D | 0.54660353 |
| 99 | CSNK2A1 | 0.54355493 |
| 100 | MAP3K4 | 0.54051854 |
| 101 | MAPKAPK3 | 0.54039923 |
| 102 | PKN1 | 0.51678831 |
| 103 | NUAK1 | 0.50616332 |
| 104 | CSNK1A1 | 0.49759653 |
| 105 | RPS6KA5 | 0.47676751 |
| 106 | EPHA4 | 0.47675872 |
| 107 | IGF1R | 0.46095395 |
| 108 | CSNK1E | 0.44738545 |
| 109 | PTK2 | 0.44372946 |
| 110 | PRKCG | 0.44276437 |
| 111 | IRAK2 | 0.44219203 |
| 112 | MAP3K5 | 0.43740152 |
| 113 | BRSK2 | 0.42776849 |
| 114 | STK16 | 0.42568843 |
| 115 | PDPK1 | 0.42186357 |
| 116 | MYLK | 0.41786780 |
| 117 | IRAK1 | 0.39971572 |
| 118 | DYRK1A | 0.39883535 |
| 119 | STK11 | 0.38082440 |
| 120 | CSNK2A2 | 0.38013792 |
| 121 | OBSCN | 0.37576002 |
| 122 | CDK4 | 0.36932524 |
| 123 | RIPK1 | 0.36911340 |
| 124 | CSNK1G2 | 0.35002573 |
| 125 | MAP2K1 | 0.34880299 |
| 126 | MAP3K6 | 0.34193728 |
| 127 | MAP3K13 | 0.33952534 |
| 128 | CSNK1G3 | 0.33785308 |
| 129 | SGK223 | 0.33650886 |
| 130 | SGK494 | 0.33650886 |
| 131 | EGFR | 0.33650480 |
| 132 | ICK | 0.32434671 |
| 133 | RET | 0.31594857 |
| 134 | AKT3 | 0.30993333 |
| 135 | CAMK4 | 0.30397901 |
| 136 | KIT | 0.27408468 |
| 137 | PRKCA | 0.26455689 |
| 138 | PDK1 | 0.26216714 |
| 139 | CSNK1A1L | 0.25800297 |
| 140 | MTOR | 0.25078321 |
| 141 | ABL1 | 0.24996037 |
| 142 | MAPK3 | 0.19865924 |
| 143 | PIK3CA | 0.18861902 |
| 144 | CHUK | 0.18265808 |
| 145 | PDK3 | 0.16447868 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.61551669 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.57372829 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.40875622 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.37614032 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.08419567 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.81073962 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70662935 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.60563792 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.59524730 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.55433457 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.43774607 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.35991514 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.27776806 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.16428332 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.10729220 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.09177610 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.01636679 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.98018117 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.96512854 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91631000 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89294050 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.89031462 |
| 23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.83796721 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82436714 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.79979894 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.75715311 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.75410051 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.73079139 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71112327 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.70571820 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.60205803 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.59922527 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.54164800 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.54050345 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.47033350 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.46440088 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.46356832 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34747248 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.33146554 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.31327058 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29843241 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29243970 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.20124310 |
| 44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.19954117 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19664062 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18083919 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.11536949 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08891091 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.08710342 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99503768 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.98523137 |
| 52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97182594 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94777132 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94751479 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91435471 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.90584444 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83327158 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.79542093 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.78878665 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77728193 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.66370036 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64050860 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63673682 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54870727 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48898884 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46671616 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.42341088 |
| 68 | Prion diseases_Homo sapiens_hsa05020 | 0.40382589 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38629863 |
| 70 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.25230478 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24720180 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23471100 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21242564 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.20393942 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18967506 |
| 76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17895948 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14789126 |
| 78 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.09879670 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07007261 |
| 80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2457329 |
| 81 | Pertussis_Homo sapiens_hsa05133 | -0.2444987 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2406615 |
| 83 | Amoebiasis_Homo sapiens_hsa05146 | -0.2384170 |
| 84 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.2351067 |
| 85 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2207053 |
| 86 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2170090 |
| 87 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2155255 |
| 88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2110137 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.2058648 |
| 90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2001232 |
| 91 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1875541 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | -0.1828818 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1808468 |
| 94 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.1792283 |
| 95 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1554390 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1517520 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1430966 |
| 98 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1385898 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1346597 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1269531 |
| 101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1154922 |
| 102 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.1149999 |
| 103 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1114117 |
| 104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1001039 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0737122 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0688794 |
| 107 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0451879 |
| 108 | Mineral absorption_Homo sapiens_hsa04978 | -0.0128097 |
| 109 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0113738 |

